New paper in Clinical Pharmacology and Therapeutics:

"The Drug Shortage Era: A Scoping Review of the Literature 2001-2019"

We reviewed *430* papers published about drug shortages in the US since 2001.

https://doi.org/10.1002/cpt.1934
This mammoth effort was in collaboration with Yizhou Cao ( @UMIOE), Gundy Sweet ( @UMichPharmacy), and Erin Fox ( @foxerinr)!
There has been A LOT of research about drug shortages in the past 20 years.

Our goals for this review were to:

- Synthesize the literature so stakeholders can see the breadth of the impact of shortages

- Produce a roadmap to help folks find new, productive research directions
Major findings:

- Drug shortages have substantial, negative impacts on the US healthcare system (incl. patient outcomes, providers, and costs)

- Much of the lit focused on the effects of shortages, their causes, how health systems have managed them, and ideas for solutions.
- There is little research on evaluating proposed solutions.
I think researchers will find the supplemental material particularly valuable. We include several tables of references by category to help folks identify relevant papers.

Part of Table S1:
As a note, our paper considers the time frame before COVID-19. Since then, we've seen numerous shortages of PPE, diagnostic kits, and medications.

Unfortunately, shortages aren't new - they've affected our healthcare system for years.

Would this era come to an end.
You can follow @EmilyLTucker.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.